Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, non-randomized, Phase II study of patients with previously untreated
NSCLC not amenable to radiotherapy or surgical treatment. The planned enrollment for this
trial is 78 patients (including a 10% rate for inevaluable patients). There will be a total
of 39 patients in each cohort (Cohorts A and B).